Eagle Rock Investment Company LLC Sells 9,470 Shares of HCA Healthcare, Inc. $HCA

Eagle Rock Investment Company LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 84.4% in the third quarter, HoldingsChannel reports. The firm owned 1,755 shares of the company’s stock after selling 9,470 shares during the period. Eagle Rock Investment Company LLC’s holdings in HCA Healthcare were worth $749,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in HCA Healthcare during the 2nd quarter valued at $5,069,974,000. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Darsana Capital Partners LP lifted its position in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in shares of HCA Healthcare during the second quarter valued at $410,992,000. Finally, Jupiter Topco LLC acquired a new stake in shares of HCA Healthcare during the second quarter valued at $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: TD Cowen raised its price target to $460 while maintaining its view on HCA, signaling continued confidence in the hospital operator’s outlook. However, the revised target implies limited near-term upside at current levels. TD Cowen raises HCA Healthcare price target
• Positive Sentiment: HCA opened a new $22 million freestanding emergency department in Florida, expanding its care network and potentially supporting long-term admissions and revenue growth. The financial impact is likely to be gradual. HCA opens new Florida freestanding emergency department
• Neutral Sentiment: The CEO of HCA Florida Capital Hospital, Dale Neely, is stepping down. The departure creates some management uncertainty, although no operational disruption or broader leadership change was reported. HCA Florida hospital CEO to exit
• Negative Sentiment: HCA is disputing North Carolina’s authority to enforce provisions of its 2019 Mission Health acquisition agreement. The legal dispute could increase regulatory scrutiny and create potential compliance costs, penalties or restrictions involving the Mission system. HCA disputes state authority over Mission deal
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors. Although such law-firm announcements do not establish wrongdoing, they add headline and litigation risk and may weigh on sentiment. Pomerantz investor investigation
• Negative Sentiment: Analysts expect a decline in HCA’s upcoming earnings, and Zacks said the company lacks the typical factors supporting a likely earnings beat. This raises caution ahead of the earnings report and may be the most direct near-term pressure on the stock. HCA earnings expectations

Analyst Ratings Changes

Several research analysts recently weighed in on HCA shares. KeyCorp cut their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research note on Monday, July 27th. BMO Capital Markets started coverage on shares of HCA Healthcare in a research note on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price target on the stock. Royal Bank Of Canada lifted their price target on shares of HCA Healthcare from $435.00 to $496.00 and gave the stock an “outperform” rating in a report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $467.61.

HCA Healthcare Trading Down 1.4%

HCA Healthcare stock opened at $459.14 on Thursday. The stock has a fifty day moving average price of $429.18 and a 200 day moving average price of $418.65. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The firm has a market capitalization of $99.40 billion, a P/E ratio of 15.37, a PEG ratio of 1.57 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.